Cargando…
COVID-19 and generalized Myasthenia Gravis exacerbation: A case report
• MG treatment in the context of COVID-19 should be tailored to the patient. • Patient’s respiratory status should be closely monitored. • Concomitant COVID-19 and MG has a variable response to treatment.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316067/ https://www.ncbi.nlm.nih.gov/pubmed/32634699 http://dx.doi.org/10.1016/j.clineuro.2020.106045 |